Loading...
12639526Q0214
Response Deadline
Jul 17, 2026, 1:00 PM(EDT)8 days
Eligibility
Contract Type
Combined Synopsis/Solicitation
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Part 12. This announcement constitutes the only solicitation. Quotations are being requested and a separate written solicitation will not be issued.
Solicitation number 12639526Q0214 is issued as a Request for Quotation (RFQ) for the following antiviral medications:
• Zanamivir (Relenza) – inhalation powder
• Oseltamivir (Tamiflu) – oral antiviral capsules
This acquisition is set-aside for small business concerns. The applicable North American Industry Classification Standard Code is 325412. The small business size standard is 1,300 employees. This acquisition is a Total Small Business Set-Aside. All responsible sources may submit a quotation which will be considered by the agency.
DEPARTMENT OF AGRICULTURE
ANIMAL AND PLANT HEALTH INSPECTION SERVICE
MRPBS MINNEAPOLIS MN
MRPBS MINNEAPOLIS MN
250 MARQUETTE AVENUE
SUITE 410
MINNEAPOLIS, MN, 55401
NAICS
Pharmaceutical Preparation Manufacturing
PSC
DRUGS AND BIOLOGICALS
Set-Aside
Total Small Business Set-Aside (FAR 19.5)